Yüklüyor......

HER2/neu Immunostaining in Invasive Breast Cancer: Analysis of False Positive Factors

OBJECTIVES: HER2/neu gene amplification by Fluorescent in situ hybridization and protein expression by immunohistochemistry have been used for prognosis and guidance for the treatment of invasive ductal carcinoma of the breast with Trastuzumab. False positive results are a significant problem where...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Arafah, Maha, Kfoury, Hala K., Zaidi, Shaesta N.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: OMJ 2010
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3191663/
https://ncbi.nlm.nih.gov/pubmed/22043354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5001/omj.2010.78
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!